28/10/201321/10/2023 Helix BioPharma Corp. announces the receipt of subscription agreements admin 0 Comments
15/10/201321/10/2023 Helix BioPharma Corp. Completes Data Review of First Four Cohorts of its Phase I/II Clinical Study for Lung Cancer Drug Candidate L-DOS47 admin 0 Comments